Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VIAV vs GSK✓SelectedUSD · GSKVIAV vs GSK performance historyLatest closeAs of+0.10%11/18
Stock and ETF performance explorer

VIAV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-40.1%
GSK return
-0.7%
Excess return
-39.4%
Maximum drawdown
-51.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.1%-1.3%+1.4%-1.3%
7D-9.7%-3.1%-6.6%-12.6%
30D-14.8%-0.9%-13.9%-14.8%
3M-28.0%-4.2%-23.8%-28.0%
6M-40.1%-1.6%-38.5%-40.0%
All-40.1%-0.7%-39.4%-40.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling